Eshan U Patel1,2, Allison R Kirkpatrick1, Mary Kate Grabowski2,3, Godfrey Kigozi3, Ronald H Gray2,3, Jessica L Prodger1,2, Andrew D Redd1,4, Fred Nalugoda3, David Serwadda3,5, Maria J Wawer2,3, Thomas C Quinn1,2,3,4, Aaron A R Tobian2,6. 1. Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, Maryland, USA. 2. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA. 3. Rakai Health Sciences Program, Entebbe, Uganda. 4. Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 5. Institute of Public Health, Makerere University, Kampala, Uganda. 6. Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract
Background: Genital immune activation is suspected to modulate local human immunodeficiency virus (HIV) RNA levels and the risk of sexual HIV transmission. Methods: A prospective, observational cohort study of 221 HIV-infected men undergoing male circumcision (MC) was conducted in Rakai, Uganda. Penile lavage samples collected from the coronal sulcus at baseline and 4 weekly visits after MC were assayed for pro-inflammatory cytokines and HIV RNA. The main analysis was limited to 175 men with detectable HIV plasma viral load (VL > 400 copies/mL; n = 808 visits). The primary exposures of interest were individual and total cytokine detection at the previous postoperative visit. Adjusted prevalence risk ratios (adjPRR) of detectable HIV shedding (VL > 40 copies/mL) were estimated by Poisson regression models with generalized estimating equations and robust variance estimators and included adjustment for plasma HIV VL. Findings: Among men with a detectable plasma VL, penile HIV shedding was detected at 136 visits (16.8%). Detectable interleukin (IL)-1β (adjPRR = 2.14; 95% confidence interval (CI) = 1.02-4.48), IL-6 (adjPRR = 2.24; 95% CI = 1.28-3.90), IL-8 (adjPRR = 2.42; 95% CI = 1.15-5.08), IL-10 (adjPRR = 2.51; 95% CI = 1.67-3.80), and IL-13 (adjPRR = 1.87; 95% CI = 1.15-3.03) were associated with penile HIV shedding at the subsequent visit. Men with 2-4 (adjPRR = 2.36; 95% CI = 1.08-5.14) and 5-7 (adjPRR = 3.00; 95% CI = 1.28-7.01) detectable cytokines had a greater likelihood of detectable penile HIV shedding at the subsequent visit, compared to men with ≤ 1 detectable cytokine. The total number of detectable cytokines was also associated with a higher penile log10 HIV VL at the subsequent visit among HIV shedders. Interpretation: Pro-inflammatory cytokine production had a dose-dependent and temporal association with penile HIV shedding, suggesting that genital immune activation may increase the risk of sexual HIV transmission by driving local HIV replication.
Background: Genital immune activation is suspected to modulate local human immunodeficiency virus (HIV) RNA levels and the risk of sexual HIV transmission. Methods: A prospective, observational cohort study of 221 HIV-infectedmen undergoing male circumcision (MC) was conducted in Rakai, Uganda. Penile lavage samples collected from the coronal sulcus at baseline and 4 weekly visits after MC were assayed for pro-inflammatory cytokines and HIV RNA. The main analysis was limited to 175 men with detectable HIV plasma viral load (VL > 400 copies/mL; n = 808 visits). The primary exposures of interest were individual and total cytokine detection at the previous postoperative visit. Adjusted prevalence risk ratios (adjPRR) of detectable HIV shedding (VL > 40 copies/mL) were estimated by Poisson regression models with generalized estimating equations and robust variance estimators and included adjustment for plasma HIV VL. Findings: Among men with a detectable plasma VL, penile HIV shedding was detected at 136 visits (16.8%). Detectable interleukin (IL)-1β (adjPRR = 2.14; 95% confidence interval (CI) = 1.02-4.48), IL-6 (adjPRR = 2.24; 95% CI = 1.28-3.90), IL-8 (adjPRR = 2.42; 95% CI = 1.15-5.08), IL-10 (adjPRR = 2.51; 95% CI = 1.67-3.80), and IL-13 (adjPRR = 1.87; 95% CI = 1.15-3.03) were associated with penile HIV shedding at the subsequent visit. Men with 2-4 (adjPRR = 2.36; 95% CI = 1.08-5.14) and 5-7 (adjPRR = 3.00; 95% CI = 1.28-7.01) detectable cytokines had a greater likelihood of detectable penile HIV shedding at the subsequent visit, compared to men with ≤ 1 detectable cytokine. The total number of detectable cytokines was also associated with a higher penile log10 HIV VL at the subsequent visit among HIV shedders. Interpretation: Pro-inflammatory cytokine production had a dose-dependent and temporal association with penile HIV shedding, suggesting that genital immune activation may increase the risk of sexual HIV transmission by driving local HIV replication.
Authors: Gabriela Paz-Bailey; Maya Sternberg; Adrian J Puren; Lisa Steele; David A Lewis Journal: Clin Infect Dis Date: 2010-04-01 Impact factor: 9.079
Authors: Catherine A Blish; R Scott McClelland; Barbra A Richardson; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh Journal: J Acquir Immune Defic Syndr Date: 2012-12-01 Impact factor: 3.731
Authors: Xiangrong Kong; Godfrey Kigozi; Joseph Ssekasanvu; Fred Nalugoda; Gertrude Nakigozi; Anthony Ndyanabo; Tom Lutalo; Steven J Reynolds; Robert Ssekubugu; Joseph Kagaayi; Eva Bugos; Larry W Chang; Pilgrim Nanlesta; Grabowski Mary; Amanda Berman; Thomas C Quinn; David Serwadda; Maria J Wawer; Ronald H Gray Journal: JAMA Date: 2016-07-12 Impact factor: 56.272
Authors: B J Dezube; M M Lederman; B Chapman; D L Georges; A L Dogon; P Mudido; J Reis-Lishing; S L Cheng; S L Silberman; C S Crumpacker Journal: J Infect Dis Date: 1997-09 Impact factor: 5.226
Authors: Prameet M Sheth; Ali Danesh; Kamnoosh Shahabi; Anuradha Rebbapragada; Colin Kovacs; Rowena Dimayuga; Roberta Halpenny; Kelly S Macdonald; Tony Mazzulli; David Kelvin; Mario Ostrowski; Rupert Kaul Journal: J Immunol Date: 2005-10-01 Impact factor: 5.422
Authors: Sara Gianella; Davey M Smith; Milenka V Vargas; Susan J Little; Douglas D Richman; Eric S Daar; Michael P Dube; Fan Zhang; Christina C Ginocchio; Richard H Haubrich; Sheldon R Morris Journal: Clin Infect Dis Date: 2013-04-17 Impact factor: 9.079
Authors: Jessica L Prodger; Ronald H Gray; Brett Shannon; Kamnoosh Shahabi; Xiangrong Kong; Kate Grabowski; Godfrey Kigozi; Fred Nalugoda; David Serwadda; Maria J Wawer; Steven J Reynolds; Cindy M Liu; Aaron A R Tobian; Rupert Kaul Journal: PLoS Pathog Date: 2016-11-29 Impact factor: 6.823